303 related articles for article (PubMed ID: 34957258)
1. The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells.
Soma Y; Morita Y; Kishino Y; Kanazawa H; Fukuda K; Tohyama S
Front Cardiovasc Med; 2021; 8():774389. PubMed ID: 34957258
[TBL] [Abstract][Full Text] [Related]
2. Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
Soma Y; Tani H; Morita-Umei Y; Kishino Y; Fukuda K; Tohyama S
J Mol Cell Cardiol; 2024 Feb; 187():90-100. PubMed ID: 38331557
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy.
Silver SE; Barrs RW; Mei Y
Front Cardiovasc Med; 2021; 8():707890. PubMed ID: 34820426
[TBL] [Abstract][Full Text] [Related]
4. Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy.
Morita Y; Kishino Y; Fukuda K; Tohyama S
Cell Prolif; 2022 Aug; 55(8):e13248. PubMed ID: 35534945
[TBL] [Abstract][Full Text] [Related]
5. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells for Heart Failure: A State-of-the-Art Review.
Kishino Y; Tohyama S; Morita Y; Soma Y; Tani H; Okada M; Kanazawa H; Fukuda K
J Card Fail; 2023 Apr; 29(4):503-513. PubMed ID: 37059512
[TBL] [Abstract][Full Text] [Related]
7. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
[TBL] [Abstract][Full Text] [Related]
8. Metabolism-based cardiomyocytes production for regenerative therapy.
Umei TC; Tohyama S; Fukuda K
J Mol Cell Cardiol; 2023 Mar; 176():11-20. PubMed ID: 36681267
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes.
Park M; Yoon YS
Korean Circ J; 2018 Nov; 48(11):974-988. PubMed ID: 30334384
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
[TBL] [Abstract][Full Text] [Related]
11. Development of Cardiac Regenerative Medicine Using Human iPS Cell-derived Cardiomyocytes.
Fujita J
Keio J Med; 2021 Sep; 70(3):53-59. PubMed ID: 32830153
[TBL] [Abstract][Full Text] [Related]
12. Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.
Lou X; Tang Y; Ye L; Pretorius D; Fast VG; Kahn-Krell AM; Zhang J; Zhang J; Qiao A; Qin G; Kamp T; Thomson JA; Zhang J
Cardiovasc Res; 2023 May; 119(4):1062-1076. PubMed ID: 36647784
[TBL] [Abstract][Full Text] [Related]
13. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
Talkhabi M; Aghdami N; Baharvand H
Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
[TBL] [Abstract][Full Text] [Related]
14. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K
J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838
[TBL] [Abstract][Full Text] [Related]
15. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
Ban K; Bae S; Yoon YS
Theranostics; 2017; 7(7):2067-2077. PubMed ID: 28638487
[TBL] [Abstract][Full Text] [Related]
16. Engineered Tissue for Cardiac Regeneration: Current Status and Future Perspectives.
Li J; Liu L; Zhang J; Qu X; Kawamura T; Miyagawa S; Sawa Y
Bioengineering (Basel); 2022 Oct; 9(11):. PubMed ID: 36354516
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Lee WH; Chen WY; Shao NY; Xiao D; Qin X; Baker N; Bae HR; Wei TT; Wang Y; Shukla P; Wu H; Kodo K; Ong SG; Wu JC
Stem Cells; 2017 Oct; 35(10):2138-2149. PubMed ID: 28710827
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells.
Moon SH; Ban K; Kim C; Kim SS; Byun J; Song MK; Park IH; Yu SP; Yoon YS
Int J Cardiol; 2013 Sep; 168(1):41-52. PubMed ID: 23044428
[TBL] [Abstract][Full Text] [Related]
19. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Matured Human Pluripotent Stem Cell-Derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts.
Dhahri W; Sadikov Valdman T; Wilkinson D; Pereira E; Ceylan E; Andharia N; Qiang B; Masoudpour H; Wulkan F; Quesnel E; Jiang W; Funakoshi S; Mazine A; Gomez-Garcia MJ; Latifi N; Jiang Y; Huszti E; Simmons CA; Keller G; Laflamme MA
Circulation; 2022 May; 145(18):1412-1426. PubMed ID: 35089805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
